The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1969, 103: 1377-1384.
Copyright © 1969 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, T. M.
Right arrow Articles by Mills, S. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Murphy, T. M.
Right arrow Articles by Mills, S. E.

Different Specificities in Antisera Prepared against Escherichia Coli Tryptophan Synthetase {alpha} Subunit1

Terence M. Murphy2 and Stanley E. Mills

From the Department of Biology, University of California, San Diego, P. O. Box 109, La Jolla, California 92037

Abstract

Four different antisera, prepared against purified Escherichia coli tryptophan synthetase {alpha} subunit using different adjuvants and schedules of injection, were examined in detail.

Each antiserum demonstrated specificity for A gene product by not reacting detectably with extracts of certain mutants which had deletions or nonsense mutations in their A genes.

Two of the antisera appeared in every way to react only with active {alpha} subunit enzyme. In contrast, the other two reacted at least partly with denatured molecules which could be produced by aging or by heating preparations containing {alpha} subunit.

In micro-complement fixation assays the latter two sera showed a variety of reactions against extracts of strains with missense A gene mutations. These reactions could be misinterpreted as cross-reactions between the sera and native, homogeneous mutant {alpha} subunit antigens.

The latter two sera also detected antigens in extracts of strains A109 and A229, strains in which A gene products had not before been demonstrated.

Footnotes

Supported in part by Atomic Energy Commission Contract AT (11-1)-34 and by Public Health Service Predoctoral Fellowship 1-F1-GM-33,440-02 (held by T.M.M.) from the National Institute of General Medical Sciences.

2 Present address: Department of Biochemistry, University of Washington, Seattle, Washington 98105.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1969 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1969 by The American Association of Immunologists, Inc. All rights reserved.